Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study

被引:2
|
作者
Vitale, Martina [1 ]
Orsi, Emanuela [2 ]
Solini, Anna [3 ]
Garofolo, Monia [4 ]
Grancini, Valeria [2 ]
Bonora, Enzo [5 ]
Fondelli, Cecilia [6 ]
Trevisan, Roberto [7 ]
Vedovato, Monica [8 ]
Penno, Giuseppe [4 ]
Nicolucci, Antonio [9 ]
Pugliese, Giuseppe [1 ]
机构
[1] Univ Roma La Sapienza, Dept Clin & Mol Med, Via Grottarossa 1035-1039, I-00189 Rome, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Diabet Unit, Milan, Italy
[3] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy
[4] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[5] Univ & Hosp Trust Verona, Div Endocrinol Diabet & Metab, Verona, Italy
[6] Univ Siena, Diabet Unit, Siena, Italy
[7] Azienda Osped Papa Giovanni XXIII, Endocrinol & Diabet Unit, Bergamo, Italy
[8] Univ Padua, Dept Clin & Expt Med, Padua, Italy
[9] Ctr Outcomes Res & Clin Epidemiol Cores, Pescara, Italy
关键词
Type; 2; diabetes; All-cause mortality; Age at diagnosis; Diabetes duration; Complications; EARLY-ONSET; YOUNG-ADULTS; COMPLICATIONS; YOUTH; ALBUMINURIA; ADOLESCENTS; DISEASE; RISK;
D O I
10.1007/s00592-024-02294-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims It is unclear whether type 2 diabetes diagnosed in young adulthood is associated with increased severity than that occurring later in life beyond longer lifetime exposure to hyperglycemia. This study aimed at assessing the independent association of age at type 2 diabetes diagnosis with all-cause mortality. Methods This prospective cohort study enrolled 15,773 Caucasian patients with type 2 diabetes in 19 Italian centers in 2006-2008. Cardiometabolic risk profile and presence of complications and comorbidities were assessed at baseline and participants were stratified by quartiles of age at diabetes diagnosis. All-cause mortality was verified on 31 October 2015. Results Valid information on vital status was retrieved for 15,656 participants (99.3%). Patients in the lowest quartile had the longest diabetes duration, the worst glycemic control and the highest prevalence of insulin treatment, obesity, atherogenic dyslipidemia, and smoking habits. All complications were inversely associated with age at diabetes diagnosis after adjustment for age and sex, but not after further adjustment for diabetes duration. Percentages of death, Kaplan-Meier estimates, and unadjusted hazard ratios and mortality rates increased from the lowest to the highest quartile. In contrast, when adjusting for age and sex, participants falling in the lowest quartile, showed the highest mortality risk [hazard ratio 1.321 (95% confidence interval 1.196-1.460), P < 0.0001]. However, differences among quartiles disappeared after adjustment for diabetes duration, complications/comorbidities, or other cardiovascular risk factors. Conclusions Type 2 diabetes onset in young adulthood is associated with increased mortality that is mainly driven by longer diabetes duration favoring the development of complications. Trial registration: ClinicalTrials.gov, NCT00715481, retrospectively registered 15 July, 2008. Conclusions Type 2 diabetes onset in young adulthood is associated with increased mortality that is mainly driven by longer diabetes duration favoring the development of complications. Trial registration: ClinicalTrials.gov, NCT00715481, retrospectively registered 15 July, 2008.
引用
收藏
页码:1107 / 1116
页数:10
相关论文
共 50 条
  • [31] Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency
    Yamamoto, Yui
    Hanai, Ko
    Mori, Tomomi
    Yokoyama, Yoichi
    Yoshida, Naoshi
    Murata, Hidekazu
    Shinozaki, Tomohiro
    Babazono, Tetsuya
    DIABETOLOGIA, 2022, 65 (01) : 234 - 245
  • [32] Association of cardiovascular health with diabetic complications, all-cause mortality, and life expectancy among people with type 2 diabetes
    Zhang, Yuan
    Yang, Rongrong
    Hou, Yabing
    Chen, Yanchun
    Li, Shu
    Wang, Yaogang
    Yang, Hongxi
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)
  • [33] Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes
    Orsi, Emanuela
    Solini, Anna
    Bonora, Enzo
    Vitale, Martina
    Garofolo, Monia
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Zerbini, Gianpaolo
    Nicolucci, Antonio
    Pugliese, Giuseppe
    DIABETES & METABOLISM, 2023, 49 (02)
  • [34] Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study
    Petersen, Irene
    Nicolaisen, Sia Kromann
    Ricciardi, Federico
    Sharma, Manuj
    Thomsen, Reimar W.
    Baio, Gianluca
    Pedersen, Lars
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 569 - 577
  • [35] Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study
    Hu, Chunyan
    Lin, Lin
    Zhu, Yujing
    Zhang, Yi
    Wang, Shuangyuan
    Zhang, Jie
    Qi, Hongyan
    Li, Mian
    Zhu, Yuanyue
    Huo, Yanan
    Wan, Qin
    Qin, Yingfen
    Hu, Ruying
    Shi, Lixin
    Su, Qing
    Yu, Xuefeng
    Yan, Li
    Qin, Guijun
    Tang, Xulei
    Chen, Gang
    Xu, Min
    Xu, Yu
    Wang, Tiange
    Zhao, Zhiyun
    Gao, Zhengnan
    Wang, Guixia
    Shen, Feixia
    Luo, Zuojie
    Chen, Li
    Li, Qiang
    Ye, Zhen
    Zhang, Yinfei
    Liu, Chao
    Wang, Youmin
    Yang, Tao
    Deng, Huacong
    Chen, Lulu
    Zeng, Tianshu
    Li, Donghui
    Zhao, Jiajun
    Mu, Yiming
    Bi, Yufang
    Wang, Weiqing
    Ning, Guang
    Wu, Shengli
    Chen, Yuhong
    Lu, Jieli
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [36] Association between the oxidative balance score and all-cause and cardiovascular mortality in patients with diabetes and prediabetes
    Xu, Zichen
    Liu, Daoqin
    Zhai, Ying
    Tang, Yu
    Jiang, Luqing
    Li, Lei
    Wu, Qiwen
    REDOX BIOLOGY, 2024, 76
  • [37] Association of pessimism with cardiovascular events and all-cause mortality
    Krittanawong, Chayakrit
    Maitra, Neil Sagar
    Khawaja, Muzamil
    Wang, Zhen
    Fogg, Sonya
    Rozenkrantz, Liron
    Virani, Salim S.
    Levin, Morris
    Storch, Eric A.
    Tobler, Philippe N.
    Charney, Dennis S.
    Levine, Glenn N.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2023, 76 : 91 - 98
  • [38] Validation in type 2 diabetes of a metabolomic signature of all-cause mortality
    Copetti, Massimiliano
    Baroni, Marco Giorgio
    Buzzetti, Raffaella
    Cavallo, Maria Gisella
    Cossu, Efiso
    D'Angelo, Paola
    De Cosmo, Salvatore
    Leonetti, Frida
    Morano, Susanna
    Morviducci, Lelio
    Napoli, Nicola
    Prudente, Sabrina
    Pugliese, Giuseppe
    Savino, Antonio Fernando
    Trischitta, Vincenzo
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2024, 40 (02)
  • [39] Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study
    Barzegar, Niloofar
    Ramezankhani, Azra
    Tohidi, Maryam
    Azizi, Fereidoun
    Hadaegh, Farzad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [40] Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study
    Garofolo, Monia
    Vitale, Martina
    Penno, Giuseppe
    Solini, Anna
    Orsi, Emanuela
    Grancini, Valeria
    Bonora, Enzo
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Nicolucci, Antonio
    Pugliese, Giuseppe
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)